Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Philips and Proscia Collaborate to Advance Open Digital Pathology Ecosystem

By Author Proscia | June 30, 2020

Collaboration aims to accelerate digital adoption through best-of-breed approach to scanning, image management, and computational pathology

PHILADELPHIA – June 30, 2020 – Proscia®, a leading provider of AI-enabled digital pathology solutions, is collaborating with Royal Philips to advance an open ecosystem that helps laboratories accelerate and scale digital pathology adoption. Through the collaboration, Proscia will integrate the Philips Pathology SDK to natively utilize Philips’ iSyntax image format with its Concentriq® digital pathology platform and suite of AI modules, providing users of Philips’ digital pathology solutions with expanded options to meet their business and workflow needs.

As laboratories shift to digital pathology, they are implementing a sophisticated ecosystem of hardware and software solutions to address the end-to-end pathology workflow. These laboratories are increasingly demanding an open approach focused on interoperability to centralize pathology operations while gaining the flexibility needed to meet current and future requirements. By incorporating the Philips medical-grade iSyntax image format into Concentriq, Philips and Proscia are providing laboratories with the freedom to choose the best components of an integrated digital pathology ecosystem and realize added value from their images.

Concentriq is an open digital pathology platform used by leading commercial and academic laboratories, as well as research organizations, to view, manage, and analyze whole slide images at an enterprise scale. In addition to offering seamless integration with multiple image formats, now including iSyntax, Concentriq is interoperable with whole slide image scanners, laboratory information systems, and image analysis applications. The platform also serves as a launchpad for computational pathology applications leveraging artificial intelligence, including solutions developed by Proscia and other third parties.

“We’re pleased to collaborate with Philips to deliver on our shared vision of an open digital pathology ecosystem,” said Coleman Stavish, Proscia’s Chief Technology Officer. “Our integrated solution is empowering a best-in-class approach to scanning, image management, and computational pathology that builds upon the industry-leading iSyntax format and provides laboratories with a future-proof approach for scaling their digital implementations.”

Availability of the Philips Pathology SDK underscores the company’s commitment to an open platform for digital pathology. As the format has distinguished features for storing pathology whole slide images, including relatively small file sizes and support for deep color with multiple color channels, millions of iSyntax images are created each year. The Pathology SDK addresses growing demands to tap into these vast repositories, providing software developers and researchers with full access to the data and information stored in the iSyntax file format.

“Through our open digital pathology platform approach, we are pleased to provide Proscia with the Pathology SDK to empower laboratories to realize the full potential of digital pathology,” said Nimish Parikh, Head of Product Management, Philips Digital & Computational Pathology. “Laboratories can now view, manage, and analyze their iSyntax images alongside all of their other pathology data in Concentriq to eliminate silos, drive efficiencies, and unlock a wealth of new information.”

Additional resources

About Proscia
Proscia is an AI software company that is changing the way the world practices pathology to transform cancer research and diagnosis. With the company’s Concentriq digital pathology platform and pipeline of AI algorithms, laboratories are leveraging new kinds of data to improve patient outcomes and accelerate discoveries. Proscia’s team of technologists, scientists, and pathologists is bringing a fresh approach to an outdated industry, helping the world to keep pace with the increasing demand for pathology services and fulfill the promise of precision care. For more information, visit

Our website uses cookies. By using this site, you agree to its use of cookies.